Healthcare Sector Stocks
The Healthcare sector has a total of 1051 stocks, with a combined market cap of $9.27 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 49.32.
Market Cap
9.27T
Revenue
4.67T
Profits
188.02B
PE Ratio
49.32
Profit Margin
4.03%
Dividend Yield
0.38%
1050 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.01T | -1.90% | 1,155,225 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 648.62B | -2.21% | 3,518,282 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 443.37B | -2.17% | 1,980,148 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 367.07B | -1.03% | 2,447,705 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 361.21B | 1.33% | 1,523,374 | 450.53B |
| 6 | NVS | Novartis AG | 294.81B | -13.97% | 6,491,521 | 56.69B |
| 7 | AZN | AstraZeneca PLC | 249.53B | -1.43% | 2,957,092 | 61.37B |
| 8 | TMO | Thermo Fisher Scientific Inc. | 223.97B | -1.31% | 802,824 | 46.34B |
| 9 | AMGN | Amgen Inc. | 214.83B | -9.12% | 3,254,919 | 38.10B |
| 10 | NVO | Novo Nordisk A/S | 205.74B | -2.64% | 5,522,707 | 50.34B |
| 11 | ABT | Abbott Laboratories | 183.39B | -2.17% | 5,816,772 | 46.59B |
| 12 | GILD | Gilead Sciences, Inc. | 181.77B | -2.92% | 1,584,215 | 30.46B |
| 13 | PFE | Pfizer Inc. | 159.22B | -1.81% | 16,262,920 | 63.70B |
| 14 | DHR | Danaher Corporation | 144.86B | -0.77% | 1,547,583 | 25.11B |
| 15 | VRTX | Vertex Pharmaceuticals Incorporated | 133.82B | -3.32% | 452,773 | 12.59B |
| 16 | BMY | Bristol-Myers Squibb Company | 132.90B | -2.63% | 3,651,143 | 49.19B |
| 17 | ISRG | Intuitive Surgical, Inc. | 124.09B | -4.21% | 1,764,788 | 11.03B |
| 18 | CVS | CVS Health Corporation | 123.41B | -0.26% | 1,536,896 | 412.65B |
| 19 | MDT | Medtronic plc | 118.47B | -1.65% | 3,518,857 | 37.54B |
| 20 | SYK | Stryker Corporation | 107.58B | -7.47% | 3,837,116 | 25.84B |
| 21 | SNY | Sanofi | 105.44B | -2.12% | 1,379,165 | 55.89B |
| 22 | MCK | McKesson Corporation | 105.13B | -0.69% | 334,417 | 410.98B |
| 23 | GSK | GSK plc | 99.72B | -2.43% | 1,777,645 | 44.05B |
| 24 | ELV | Elevance Health, Inc. | 87.67B | -0.80% | 473,250 | 201.11B |
| 25 | HCA | HCA Healthcare, Inc. | 86.73B | -1.09% | 865,662 | 78.01B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 81.02B | -1.97% | 229,201 | 15.53B |
| 27 | CI | The Cigna Group | 73.31B | -1.80% | 836,915 | 282.38B |
| 28 | BSX | Boston Scientific Corporation | 65.51B | -5.44% | 14,231,820 | 21.00B |
| 29 | ARGX | argenx SE | 63.22B | -2.27% | 119,353 | 5.32B |
| 30 | COR | Cencora, Inc. | 62.65B | -0.80% | 586,032 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 59.62B | -0.65% | 1,438,220 | 28.42B |
| 32 | MRNA | Moderna, Inc. | 57.39B | -1.24% | 6,186,887 | 2.23B |
| 33 | CAH | Cardinal Health, Inc. | 55.91B | -2.74% | 590,531 | 254.25B |
| 34 | EW | Edwards Lifesciences Corporation | 50.25B | -3.03% | 1,016,832 | 6.51B |
| 35 | BDX | Becton, Dickinson and Company | 48.98B | -2.67% | 711,175 | 22.48B |
| 36 | HUM | Humana Inc. | 48.86B | 1.33% | 221,044 | 145.68B |
| 37 | NTRA | Natera, Inc. | 47.72B | 0.88% | 493,909 | 2.71B |
| 38 | MDLN | Medline Inc. | 46.59B | -3.14% | 3,279,029 | 29.94B |
| 39 | RVMD | Revolution Medicines, Inc. | 45.11B | 0.22% | 676,156 | - |
| 40 | IQV | IQVIA Holdings Inc. | 43.31B | -1.74% | 493,606 | 16.98B |
| 41 | VEEV | Veeva Systems Inc. | 42.87B | -3.75% | 602,270 | 3.46B |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 42.67B | 0.72% | 2,046,011 | 17.32B |
| 43 | A | Agilent Technologies, Inc. | 41.70B | -1.96% | 583,237 | 7.37B |
| 44 | IDXX | IDEXX Laboratories, Inc. | 41.57B | -1.43% | 190,461 | 4.55B |
| 45 | HLN | Haleon plc | 40.96B | -3.75% | 12,512,174 | 14.80B |
| 46 | ONC | BeOne Medicines AG | 39.73B | -2.47% | 201,283 | 6.13B |
| 47 | WAT | Waters Corporation | 39.72B | -1.26% | 128,686 | 4.64B |
| 48 | ALNY | Alnylam Pharmaceuticals, Inc. | 34.91B | -1.96% | 957,518 | 4.80B |
| 49 | RPRX | Royalty Pharma plc | 34.72B | -5.58% | 3,587,802 | 2.54B |
| 50 | ALC | Alcon Inc. | 34.04B | -1.70% | 899,237 | 10.86B |
| 51 | CNC | Centene Corporation | 32.61B | -1.54% | 1,419,343 | 180.30B |
| 52 | ILMN | Illumina, Inc. | 32.50B | -1.36% | 802,497 | 4.49B |
| 53 | DXCM | DexCom, Inc. | 32.22B | -2.87% | 2,250,021 | 4.97B |
| 54 | RMD | ResMed Inc. | 32.00B | -2.86% | 423,388 | 5.65B |
| 55 | BIIB | Biogen Inc. | 31.58B | -3.22% | 290,024 | 10.03B |
| 56 | ZTS | Zoetis Inc. | 30.76B | -1.82% | 2,063,115 | 9.53B |
| 57 | GEHC | GE HealthCare Technologies Inc. | 30.43B | -2.18% | 1,261,256 | 21.27B |
| 58 | ROIV | Roivant Sciences Ltd. | 30.36B | 20.34% | 15,285,169 | 7.53M |
| 59 | INSM | Insmed Incorporated | 27.51B | -0.24% | 704,296 | 1.14B |
| 60 | MTD | Mettler-Toledo International Inc. | 26.77B | -0.70% | 51,926 | 4.13B |
| 61 | LH | Labcorp Holdings Inc. | 26.37B | -0.55% | 248,487 | 14.35B |
| 62 | DGX | Quest Diagnostics Incorporated | 26.13B | -0.17% | 302,872 | 11.56B |
| 63 | INCY | Incyte Corporation | 25.47B | -0.88% | 377,952 | 5.82B |
| 64 | PHG | Koninklijke Philips N.V. | 25.13B | -1.85% | 386,133 | 20.18B |
| 65 | BNTX | BioNTech SE | 25.07B | -3.82% | 655,108 | 3.03B |
| 66 | WST | West Pharmaceutical Services, Inc. | 23.73B | -0.83% | 209,876 | 3.33B |
| 67 | GH | Guardant Health, Inc. | 22.23B | 2.65% | 1,006,238 | 1.18B |
| 68 | UTHR | United Therapeutics Corporation | 21.51B | 2.85% | 334,905 | 3.15B |
| 69 | STE | STERIS plc | 21.47B | -1.93% | 277,066 | 6.04B |
| 70 | THC | Tenet Healthcare Corporation | 20.93B | -1.93% | 301,112 | 21.81B |
| 71 | GMAB | Genmab A/S | 20.11B | 0.54% | 744,542 | 4.13B |
| 72 | VTRS | Viatris Inc. | 19.10B | -1.48% | 1,718,599 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.83B | -4.68% | 1,810,842 | 8.51B |
| 74 | ASND | Ascendis Pharma A/S | 17.66B | -0.61% | 192,170 | 1.20B |
| 75 | MEDP | Medpace Holdings, Inc. | 16.50B | 0.01% | 79,249 | 2.78B |
| 76 | NBIX | Neurocrine Biosciences, Inc. | 15.90B | 0.49% | 302,391 | 3.37B |
| 77 | JAZZ | Jazz Pharmaceuticals plc | 15.63B | -2.47% | 186,823 | 4.60B |
| 78 | SOLV | Solventum Corporation | 15.35B | -1.63% | 331,521 | 8.31B |
| 79 | BBIO | BridgeBio Pharma, Inc. | 14.62B | -0.08% | 674,448 | 713.07M |
| 80 | EXEL | Exelixis, Inc. | 14.54B | -0.54% | 745,731 | 2.44B |
| 81 | RVTY | Revvity, Inc. | 14.28B | -1.70% | 410,785 | 2.91B |
| 82 | SMMT | Summit Therapeutics Inc. | 13.97B | -0.54% | 3,379,673 | - |
| 83 | CRL | Charles River Laboratories International, Inc. | 13.47B | -2.19% | 255,211 | 4.00B |
| 84 | COO | The Cooper Companies, Inc. | 13.31B | -1.91% | 973,982 | 4.23B |
| 85 | BTSG | BrightSpring Health Services, Inc. | 13.03B | 3.01% | 565,018 | 14.37B |
| 86 | BAX | Baxter International Inc. | 12.87B | -3.64% | 2,563,935 | 11.47B |
| 87 | BMRN | BioMarin Pharmaceutical Inc. | 12.63B | -1.92% | 527,193 | 3.41B |
| 88 | PEN | Penumbra, Inc. | 12.60B | -0.70% | 201,099 | 1.50B |
| 89 | ICLR | ICON Public Limited Company | 12.43B | -2.30% | 240,011 | 8.29B |
| 90 | CORT | Corcept Therapeutics Incorporated | 12.41B | 2.85% | 311,951 | 830.81M |
| 91 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.37B | -1.08% | 83,432 | 1.28B |
| 92 | HALO | Halozyme Therapeutics, Inc. | 12.28B | -1.82% | 644,800 | 1.66B |
| 93 | ARWR | Arrowhead Pharmaceuticals, Inc. | 12.14B | -0.45% | 574,370 | 669.50M |
| 94 | SNN | Smith & Nephew plc | 12.12B | -3.43% | 2,656,774 | 6.30B |
| 95 | FMS | Fresenius Medical Care AG | 12.11B | -0.79% | 497,742 | 22.19B |
| 96 | ELAN | Elanco Animal Health Incorporated | 12.03B | -1.76% | 1,248,197 | 5.02B |
| 97 | EHC | Encompass Health Corporation | 11.92B | -0.79% | 219,521 | 6.21B |
| 98 | TEM | Tempus AI, Inc. | 11.77B | 0.94% | 3,051,397 | 1.43B |
| 99 | DVA | DaVita Inc. | 11.62B | -0.96% | 242,842 | 14.01B |
| 100 | TECH | Bio-Techne Corporation | 11.34B | -0.12% | 1,103,515 | 1.22B |
| 101 | ALGN | Align Technology, Inc. | 11.03B | -2.15% | 277,648 | 4.14B |
| 102 | AXSM | Axsome Therapeutics, Inc. | 10.88B | 0.47% | 128,336 | 776.57M |
| 103 | GKOS | Glaukos Corporation | 10.87B | 3.93% | 263,237 | 612.84M |
| 104 | CYTK | Cytokinetics, Incorporated | 10.60B | 4.88% | 1,097,188 | 67.67M |
| 105 | KRYS | Krystal Biotech, Inc. | 10.48B | -1.21% | 88,752 | 440.48M |
| 106 | MOH | Molina Healthcare, Inc. | 10.32B | -1.35% | 114,497 | 42.47B |
| 107 | BIO | Bio-Rad Laboratories, Inc. | 10.22B | -1.01% | 38,370 | 2.59B |
| 108 | AVTR | Avantor, Inc. | 10.21B | 0.80% | 4,817,810 | 6.56B |
| 109 | OSCR | Oscar Health, Inc. | 10.20B | 2.54% | 1,978,174 | 15.32B |
| 110 | GMED | Globus Medical, Inc. | 10.15B | -3.45% | 651,233 | 3.14B |
| 111 | RDY | Dr. Reddy's Laboratories Limited | 10.08B | -1.13% | 1,144,359 | 3.50B |
| 112 | UHS | Universal Health Services, Inc. | 9.99B | -0.06% | 289,876 | 18.11B |
| 113 | HSIC | Henry Schein, Inc. | 9.96B | -0.53% | 223,853 | 13.60B |
| 114 | ABVX | ABIVAX Société Anonyme | 9.93B | 4.37% | 1,074,273 | 5.67M |
| 115 | PRAX | Praxis Precision Medicines, Inc. | 9.91B | 0.93% | 140,522 | 7.46M |
| 116 | ENSG | The Ensign Group, Inc. | 9.90B | 0.35% | 101,707 | 5.49B |
| 117 | KYMR | Kymera Therapeutics, Inc. | 9.90B | 1.43% | 246,761 | 105.00M |
| 118 | PODD | Insulet Corporation | 9.81B | -4.13% | 884,686 | 3.05B |
| 119 | RGEN | Repligen Corporation | 9.59B | 1.41% | 342,957 | 785.10M |
| 120 | PTGX | Protagonist Therapeutics, Inc. | 9.51B | 0.89% | 183,439 | 281.99M |
| 121 | IONS | Ionis Pharmaceuticals, Inc. | 9.38B | -2.82% | 6,203,199 | 874.09M |
| 122 | PCVX | Vaxcyte, Inc. | 9.00B | -1.06% | 465,633 | - |
| 123 | IBRX | ImmunityBio, Inc. | 8.80B | 2.78% | 4,193,307 | 165.79M |
| 124 | QGEN | Qiagen N.V. | 8.80B | -2.12% | 715,486 | 2.10B |
| 125 | BRKR | Bruker Corporation | 8.79B | -1.36% | 381,751 | 3.50B |
| 126 | TXG | 10x Genomics, Inc. | 8.58B | 5.08% | 1,410,812 | 616.91M |
| 127 | IMVT | Immunovant, Inc. | 8.23B | 1.55% | 533,132 | - |
| 128 | TWST | Twist Bioscience Corporation | 8.22B | 5.11% | 943,432 | 431.80M |
| 129 | SYRE | Spyre Therapeutics, Inc. | 8.03B | 2.37% | 752,381 | - |
| 130 | ATR | AptarGroup, Inc. | 7.98B | -1.43% | 89,287 | 3.93B |
| 131 | TGTX | TG Therapeutics, Inc. | 7.89B | -0.62% | 513,238 | 799.54M |
| 132 | BLTE | Belite Bio, Inc | 7.87B | 0.98% | 346,259 | - |
| 133 | ALKS | Alkermes plc | 7.77B | 0.49% | 593,929 | 1.67B |
| 134 | HQY | HealthEquity, Inc. | 7.77B | -2.26% | 469,094 | 1.36B |
| 135 | HNGE | Hinge Health, Inc. | 7.41B | -0.56% | 618,812 | 720.06M |
| 136 | CAI | Caris Life Sciences, Inc. | 7.23B | 2.03% | 2,454,575 | 989.61M |
| 137 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.05B | -0.28% | 215,696 | 239.92M |
| 138 | SRRK | Scholar Rock Holding Corporation | 6.95B | 3.07% | 465,826 | - |
| 139 | PACS | PACS Group, Inc. | 6.94B | 3.08% | 196,887 | 5.55B |
| 140 | GRFS | Grifols, S.A. | 6.85B | -0.06% | 223,926 | 8.48B |
| 141 | CHE | Chemed Corporation | 6.81B | 0.60% | 73,438 | 2.60B |
| 142 | CGON | CG Oncology, Inc. | 6.58B | -0.62% | 187,236 | 6.23M |
| 143 | LNTH | Lantheus Holdings, Inc. | 6.57B | -0.38% | 376,979 | 1.56B |
| 144 | MIRM | Mirum Pharmaceuticals, Inc. | 6.54B | -0.24% | 328,772 | 618.07M |
| 145 | HIMS | Hims & Hers Health, Inc. | 6.52B | 0.92% | 4,591,266 | 2.58B |
| 146 | MMED | MiniMed Group, Inc. | 6.43B | -1.61% | 281,095 | 3.22B |
| 147 | ORKA | Oruka Therapeutics, Inc. | 6.34B | 3.49% | 389,718 | - |
| 148 | BLCO | Bausch + Lomb Corporation | 6.31B | -2.00% | 143,931 | 5.32B |
| 149 | TVTX | Travere Therapeutics, Inc. | 6.20B | 0.78% | 691,439 | 591.33M |
| 150 | DNTH | Dianthus Therapeutics, Inc. | 6.17B | 2.01% | 259,947 | 1.90M |
| 151 | LQDA | Liquidia Corporation | 6.10B | -0.74% | 675,089 | 450.91M |
| 152 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.09B | 0.16% | 315,535 | 840.85M |
| 153 | COGT | Cogent Biosciences, Inc. | 6.09B | 0.86% | 690,513 | - |
| 154 | AMRX | Amneal Pharmaceuticals, Inc. | 5.98B | -1.55% | 694,565 | 3.12B |
| 155 | PTCT | PTC Therapeutics, Inc. | 5.84B | 1.04% | 395,083 | 1.01B |
| 156 | XENE | Xenon Pharmaceuticals Inc. | 5.82B | 0.57% | 336,661 | 7.50M |
| 157 | ERAS | Erasca, Inc. | 5.80B | 2.41% | 2,368,935 | - |
| 158 | TFX | Teleflex Incorporated | 5.77B | -1.59% | 200,973 | 2.25B |
| 159 | RDNT | RadNet, Inc. | 5.72B | -1.33% | 115,007 | 2.27B |
| 160 | LGND | Ligand Pharmaceuticals Incorporated | 5.63B | -1.05% | 64,622 | 290.54M |
| 161 | STVN | Stevanato Group S.p.A. | 5.60B | - | 117,695 | 1.40B |
| 162 | SHC | Sotera Health Company | 5.35B | -0.82% | 699,274 | 1.22B |
| 163 | CRSP | CRISPR Therapeutics AG | 5.31B | -1.51% | 902,666 | 13.39M |
| 164 | MMSI | Merit Medical Systems, Inc. | 5.23B | -2.16% | 140,201 | 1.58B |
| 165 | DFTX | Definium Therapeutics, Inc. | 5.22B | 2.01% | 805,319 | - |
| 166 | PBLS | Parabilis Medicines, Inc. | 4.90B | -1.94% | 293,873 | 148.00K |
| 167 | LFST | LifeStance Health Group, Inc. | 4.88B | 0.24% | 1,108,541 | 1.58B |
| 168 | ACAD | ACADIA Pharmaceuticals Inc. | 4.82B | -0.14% | 555,722 | 1.14B |
| 169 | EWTX | Edgewise Therapeutics, Inc. | 4.79B | 2.51% | 580,786 | - |
| 170 | BLLN | BillionToOne, Inc. | 4.74B | 1.10% | 249,599 | 397.41M |
| 171 | WAY | Waystar Holding Corp. | 4.73B | -1.60% | 393,860 | 1.21B |
| 172 | CELC | Celcuity Inc. | 4.70B | 0.45% | 347,055 | - |
| 173 | HAE | Haemonetics Corporation | 4.68B | -0.05% | 217,215 | 1.35B |
| 174 | LIVN | LivaNova PLC | 4.47B | -1.01% | 130,735 | 1.47B |
| 175 | DOCS | Doximity, Inc. | 4.41B | -6.03% | 1,393,077 | 655.57M |
| 176 | CON | Concentra Group Holdings Parent, Inc. | 4.39B | -0.23% | 289,144 | 2.29B |
| 177 | ELVN | Enliven Therapeutics, Inc. | 4.37B | 0.49% | 348,609 | - |
| 178 | NVST | Envista Holdings Corporation | 4.33B | -1.17% | 1,134,251 | 2.86B |
| 179 | HTFL | HeartFlow, Inc. | 4.32B | 1.51% | 1,257,630 | 212.07M |
| 180 | ITGR | Integer Holdings Corporation | 4.30B | -0.04% | 241,906 | 1.84B |
| 181 | AMLX | Amylyx Pharmaceuticals, Inc. | 4.27B | -0.15% | 463,603 | -665.00K |
| 182 | MANE | Veradermics, Incorporated | 4.25B | 3.20% | 293,212 | - |
| 183 | RLAY | Relay Therapeutics, Inc. | 4.15B | -0.42% | 1,383,907 | 10.35M |
| 184 | INDV | Indivior Pharmaceuticals, Inc. | 4.06B | -1.49% | 551,494 | 1.33B |
| 185 | TLX | Telix Pharmaceuticals Limited | 4.05B | 1.26% | 196,262 | 890.79M |
| 186 | ICUI | ICU Medical, Inc. | 4.04B | -3.53% | 89,744 | 2.16B |
| 187 | IRTC | iRhythm Holdings, Inc. | 4.02B | -1.00% | 213,424 | 825.34M |
| 188 | LEGN | Legend Biotech Corporation | 4.00B | -4.07% | 922,720 | 1.27B |
| 189 | IOVA | Iovance Biotherapeutics, Inc. | 3.99B | 0.17% | 4,589,835 | 324.97M |
| 190 | VKTX | Viking Therapeutics, Inc. | 3.96B | -2.61% | 909,725 | - |
| 191 | ADPT | Adaptive Biotechnologies Corporation | 3.91B | 1.03% | 624,841 | 308.08M |
| 192 | TARS | Tarsus Pharmaceuticals, Inc. | 3.91B | -1.88% | 883,714 | 606.33M |
| 193 | DYN | Dyne Therapeutics, Inc. | 3.88B | -14.37% | 11,553,377 | - |
| 194 | TNGX | Tango Therapeutics, Inc. | 3.86B | 1.73% | 778,059 | 53.81M |
| 195 | IDYA | IDEAYA Biosciences, Inc. | 3.78B | -1.66% | 369,935 | 234.13M |
| 196 | RCUS | Arcus Biosciences, Inc. | 3.75B | -0.81% | 865,787 | 117.00M |
| 197 | ABCL | AbCellera Biologics Inc. | 3.72B | 0.44% | 1,463,329 | 66.17M |
| 198 | OGN | Organon & Co. | 3.62B | -0.04% | 686,711 | 6.13B |
| 199 | GRAL | GRAIL, Inc. | 3.58B | -0.32% | 376,167 | 165.26M |
| 200 | OPCH | Option Care Health, Inc. | 3.57B | -1.61% | 527,898 | 5.69B |
| 201 | PLSE | Pulse Biosciences, Inc. | 3.56B | -6.29% | 455,769 | 1.19M |
| 202 | DNLI | Denali Therapeutics Inc. | 3.55B | -0.31% | 825,989 | 3.60M |
| 203 | VCYT | Veracyte, Inc. | 3.46B | 1.20% | 293,516 | 561.90M |
| 204 | NHC | National HealthCare Corporation | 3.45B | 0.64% | 40,257 | 1.56B |
| 205 | RGC | Regencell Bioscience Holdings Limited | 3.37B | -1.31% | 244,167 | - |
| 206 | GPCR | Structure Therapeutics Inc. | 3.17B | -6.17% | 1,618,395 | - |
| 207 | CLDX | Celldex Therapeutics, Inc. | 3.11B | -0.30% | 360,735 | 158.00K |
| 208 | QURE | uniQure N.V. | 3.09B | -0.02% | 394,165 | 18.67M |
| 209 | IMNM | Immunome, Inc. | 3.08B | 1.44% | 383,242 | 4.02M |
| 210 | ARQT | Arcutis Biotherapeutics, Inc. | 3.07B | 2.22% | 2,202,431 | 463.98M |
| 211 | WRBY | Warby Parker Inc. | 3.06B | 1.60% | 1,387,985 | 911.61M |
| 212 | MBX | MBX Biosciences, Inc. | 3.05B | 2.75% | 116,551 | - |
| 213 | TMDX | TransMedics Group, Inc. | 3.05B | -2.24% | 212,094 | 668.47M |
| 214 | AVAH | Aveanna Healthcare Holdings Inc. | 3.03B | 2.14% | 2,980,131 | 2.60B |
| 215 | IRON | Disc Medicine, Inc. | 2.98B | -2.02% | 125,877 | - |
| 216 | NAMS | NewAmsterdam Pharma Company N.V. | 2.95B | -2.76% | 2,211,461 | 7.12M |
| 217 | ZLAB | Zai Lab Limited | 2.93B | -0.50% | 459,051 | 449.61M |
| 218 | BKD | Brookdale Senior Living Inc. | 2.89B | 2.85% | 1,217,690 | 2.93B |
| 219 | SLS | SELLAS Life Sciences Group, Inc. | 2.81B | 0.51% | 4,257,972 | - |
| 220 | ALHC | Alignment Healthcare, Inc. | 2.79B | -0.52% | 1,998,130 | 4.58B |
| 221 | MLYS | Mineralys Therapeutics, Inc. | 2.75B | 10.44% | 1,331,810 | - |
| 222 | ATAI | AtaiBeckley Inc. | 2.73B | -0.47% | 11,465,470 | 4.47M |
| 223 | ATRC | AtriCure, Inc. | 2.71B | 3.38% | 916,366 | 569.62M |
| 224 | BEAM | Beam Therapeutics Inc. | 2.71B | -8.60% | 4,276,825 | 156.04M |
| 225 | NRIX | Nurix Therapeutics, Inc. | 2.70B | -0.33% | 793,638 | 36.77M |
| 226 | VRDN | Viridian Therapeutics, Inc. | 2.68B | 3.32% | 830,578 | 71.13M |
| 227 | PRVA | Privia Health Group, Inc. | 2.67B | 1.36% | 456,536 | 2.36B |
| 228 | PHVS | Pharvaris N.V. | 2.67B | 7.83% | 4,366,862 | - |
| 229 | GRDN | Guardian Pharmacy Services, Inc. | 2.66B | 3.09% | 286,037 | 1.46B |
| 230 | NKTR | Nektar Therapeutics | 2.61B | 2.90% | 476,928 | 54.59M |
| 231 | CDNA | CareDx, Inc. | 2.60B | -1.23% | 498,089 | 458.09M |
| 232 | NEOG | Neogen Corporation | 2.60B | 0.76% | 944,371 | 870.40M |
| 233 | WGS | GeneDx Holdings Corp. | 2.57B | 0.30% | 197,648 | 454.43M |
| 234 | ACHC | Acadia Healthcare Company, Inc. | 2.57B | -1.99% | 385,438 | 3.37B |
| 235 | VERA | Vera Therapeutics, Inc. | 2.54B | -1.98% | 441,110 | - |
| 236 | AXGN | Axogen, Inc. | 2.52B | -2.98% | 224,703 | 251.17M |
| 237 | HRMY | Harmony Biosciences Holdings, Inc. | 2.51B | 1.85% | 714,781 | 959.90M |
| 238 | PGEN | Precigen, Inc. | 2.50B | -1.76% | 1,262,089 | 85.72M |
| 239 | SUPN | Supernus Pharmaceuticals, Inc. | 2.47B | -2.41% | 160,031 | 830.44M |
| 240 | OCUL | Ocular Therapeutix, Inc. | 2.46B | 5.45% | 1,191,250 | 52.06M |
| 241 | BHC | Bausch Health Companies Inc. | 2.44B | -0.46% | 850,330 | 10.85B |
| 242 | HCM | HUTCHMED (China) Limited | 2.44B | -1.45% | 78,092 | 549.12M |
| 243 | TRLV | Trulieve Cannabis Corp. | 2.42B | 3.96% | 1,440,530 | 1.14B |
| 244 | TRVI | Trevi Therapeutics, Inc. | 2.41B | -2.11% | 808,707 | - |
| 245 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.38B | -6.68% | 6,731,119 | 940.61M |
| 246 | PBH | Prestige Consumer Healthcare Inc. | 2.37B | -4.15% | 133,718 | 1.10B |
| 247 | NUVB | Nuvation Bio Inc. | 2.34B | -2.06% | 990,793 | 169.90M |
| 248 | CLOV | Clover Health Investments, Corp. | 2.30B | 1.76% | 1,669,145 | 2.48B |
| 249 | BHVN | Biohaven Ltd. | 2.28B | -3.76% | 1,742,524 | - |
| 250 | NEO | NeoGenomics, Inc. | 2.27B | 1.78% | 428,719 | 766.30M |
| 251 | PVLA | Palvella Therapeutics, Inc. | 2.27B | 0.04% | 83,355 | - |
| 252 | RAPP | Rapport Therapeutics, Inc. | 2.22B | 1.30% | 180,287 | 20.00M |
| 253 | ESTA | Establishment Labs Holdings Inc. | 2.21B | -0.01% | 164,002 | 245.82M |
| 254 | XRAY | DENTSPLY SIRONA Inc. | 2.21B | -2.46% | 1,208,375 | 3.64B |
| 255 | SRPT | Sarepta Therapeutics, Inc. | 2.19B | -8.00% | 3,076,569 | 1.97B |
| 256 | ADUS | Addus HomeCare Corporation | 2.18B | 0.30% | 58,902 | 1.48B |
| 257 | ZBIO | Zenas BioPharma, Inc. | 2.17B | 1.31% | 208,390 | 1.00M |
| 258 | KOD | Kodiak Sciences Inc. | 2.17B | -2.12% | 237,983 | - |
| 259 | URGN | UroGen Pharma Ltd. | 2.16B | 0.45% | 162,618 | 188.73M |
| 260 | AUPH | Aurinia Pharmaceuticals Inc. | 2.16B | 1.00% | 312,381 | 311.51M |
| 261 | UFPT | UFP Technologies, Inc. | 2.16B | -3.51% | 67,975 | 631.64M |
| 262 | MESO | Mesoblast Limited | 2.15B | -4.73% | 81,407 | 120.25M |
| 263 | KLRA | Kailera Therapeutics, Inc. | 2.14B | 1.85% | 445,658 | - |
| 264 | ADMA | ADMA Biologics, Inc. | 2.14B | -0.68% | 880,613 | 512.28M |
| 265 | MD | Pediatrix Medical Group, Inc. | 2.12B | -0.96% | 165,562 | 1.95B |
| 266 | ALMR | Alamar Biosciences, Inc. | 2.09B | -2.05% | 81,320 | 100.42M |
| 267 | COAG | Hemab Therapeutics Holdings, Inc. | 2.09B | 0.86% | 164,459 | - |
| 268 | PGNY | Progyny, Inc. | 2.09B | 4.82% | 1,012,563 | 1.31B |
| 269 | GENB | Generate Biomedicines, Inc. | 2.05B | -2.38% | 880,389 | 26.48M |
| 270 | NVCR | NovoCure Limited | 2.04B | -2.40% | 201,541 | 699.19M |
| 271 | ZYME | Zymeworks Inc. | 2.03B | -1.82% | 172,973 | 37.13M |
| 272 | PRGO | Perrigo Company plc | 2.02B | -2.48% | 1,116,530 | 4.14B |
| 273 | AGIO | Agios Pharmaceuticals, Inc. | 2.01B | 1.89% | 286,961 | 98.34M |
| 274 | KARD | Kardigan, Inc. | 2.01B | 3.09% | 295,296 | - |
| 275 | VCEL | Vericel Corporation | 2.01B | -2.36% | 179,004 | 306.30M |
| 276 | BFLY | Butterfly Network, Inc. | 2.00B | 1.90% | 1,358,893 | 112.14M |
| 277 | CMPS | COMPASS Pathways plc | 1.98B | 7.76% | 1,916,945 | - |
| 278 | STOK | Stoke Therapeutics, Inc. | 1.97B | 2.45% | 277,054 | 27.59M |
| 279 | NBTX | Nanobiotix S.A. | 1.96B | -2.58% | 36,714 | 38.27M |
| 280 | ASTH | Astrana Health, Inc. | 1.94B | -1.22% | 93,556 | 3.84B |
| 281 | GHRS | GH Research PLC | 1.91B | -1.66% | 124,835 | - |
| 282 | VIR | Vir Biotechnology, Inc. | 1.90B | -1.19% | 634,932 | 303.23M |
| 283 | ALVO | Alvotech | 1.89B | -0.56% | 359,451 | 494.61M |
| 284 | XNCR | Xencor, Inc. | 1.89B | -4.66% | 563,532 | 104.97M |
| 285 | RXRX | Recursion Pharmaceuticals, Inc. | 1.87B | -3.86% | 9,630,158 | 54.86M |
| 286 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.87B | -1.57% | 786,321 | 208.78M |
| 287 | SNDA | Sonida Senior Living, Inc. | 1.85B | 3.82% | 187,494 | 481.07M |
| 288 | LKFT | Lakefront Biotherapeutics NV | 1.85B | -2.53% | 82,445 | 1.13B |
| 289 | DMRA | Damora Therapeutics, Inc. | 1.84B | -0.70% | 245,533 | - |
| 290 | SGRY | Surgery Partners, Inc. | 1.84B | -0.56% | 1,017,583 | 3.37B |
| 291 | BRVE | Braveheart Bio, Inc. | 1.83B | 6.66% | 404,640 | - |
| 292 | IMCR | Immunocore Holdings plc | 1.82B | -1.94% | 343,272 | 430.78M |
| 293 | LMAT | LeMaitre Vascular, Inc. | 1.81B | -1.65% | 74,912 | 262.43M |
| 294 | SNDX | Syndax Pharmaceuticals, Inc. | 1.81B | -1.22% | 495,787 | 252.25M |
| 295 | NTLA | Intellia Therapeutics, Inc. | 1.80B | 0.94% | 2,752,771 | 59.51M |
| 296 | INSP | Inspire Medical Systems, Inc. | 1.80B | -1.31% | 215,492 | 898.74M |
| 297 | PSNL | Personalis, Inc. | 1.80B | -2.21% | 785,946 | 69.67M |
| 298 | TSHA | Taysha Gene Therapies, Inc. | 1.79B | -2.14% | 604,147 | 5.49M |
| 299 | SEPN | Septerna, Inc. | 1.77B | 3.12% | 139,074 | 98.88M |
| 300 | FRNM | Freenome, Inc. | 1.76B | 0.28% | 259,592 | 35.41M |
| 301 | BLFS | BioLife Solutions, Inc. | 1.75B | 1.30% | 352,861 | 106.69M |
| 302 | ANAB | AnaptysBio, Inc. | 1.70B | 1.25% | 623,936 | 232.39M |
| 303 | NVAX | Novavax, Inc. | 1.70B | 0.93% | 2,574,278 | 413.80M |
| 304 | AVLN | Avalyn Pharma Inc. | 1.70B | 2.37% | 116,746 | - |
| 305 | ETON | Eton Pharmaceuticals, Inc. | 1.69B | 1.40% | 183,257 | 105.60M |
| 306 | TYRA | Tyra Biosciences, Inc. | 1.67B | -2.20% | 535,033 | - |
| 307 | FTRE | Fortrea Holdings Inc. | 1.66B | -1.58% | 803,145 | 2.68B |
| 308 | APMD | Apnimed, Inc. | 1.62B | 6.67% | 203,290 | 120.15M |
| 309 | INBX | Inhibrx Biosciences, Inc. | 1.61B | -9.76% | 1,197,910 | 1.30M |
| 310 | AAPG | Ascentage Pharma Group International | 1.60B | -2.07% | 7,726 | 94.61M |
| 311 | LTGO | Latigo Biotherapeutics, Inc. | 1.58B | 3.34% | 169,625 | - |
| 312 | LBRX | LB Pharmaceuticals Inc | 1.57B | -1.24% | 167,589 | - |
| 313 | BCAX | Bicara Therapeutics Inc. | 1.56B | 1.90% | 252,152 | - |
| 314 | ABSI | Absci Corporation | 1.56B | 2.95% | 1,486,524 | 1.56M |
| 315 | OMCL | Omnicell, Inc. | 1.55B | -1.28% | 173,135 | 1.25B |
| 316 | XERS | Xeris Biopharma Holdings, Inc. | 1.55B | -0.53% | 478,763 | 335.41M |
| 317 | AVBP | ArriVent BioPharma, Inc. | 1.54B | 1.16% | 504,842 | - |
| 318 | INVA | Innoviva, Inc. | 1.54B | - | 248,956 | 440.00M |
| 319 | AGL | agilon health, inc. | 1.53B | 3.10% | 52,169 | 5.92B |
| 320 | PAHC | Phibro Animal Health Corporation | 1.53B | -1.48% | 55,631 | 1.52B |
| 321 | VOR | Vor Biopharma Inc. | 1.53B | 3.23% | 443,279 | - |
| 322 | ANIP | ANI Pharmaceuticals, Inc. | 1.52B | -0.39% | 105,824 | 978.38M |
| 323 | ARDT | Ardent Health, Inc. | 1.52B | -1.37% | 199,170 | 6.41B |
| 324 | TRAX | First Tracks Biotherapeutics, Inc. | 1.51B | 4.57% | 242,986 | - |
| 325 | HCSG | Healthcare Services Group, Inc. | 1.50B | 0.32% | 277,756 | 1.86B |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.50B | -0.10% | 119,272 | 95.13M |
| 327 | SLBT | SL Science Holding Limited | 1.49B | -9.55% | 87,761 | 3.27M |
| 328 | SDGR | Schrödinger, Inc. | 1.48B | -1.24% | 388,741 | 259.04M |
| 329 | MAZE | Maze Therapeutics, Inc. | 1.46B | 0.61% | 133,450 | 20.00M |
| 330 | RARE | Ultragenyx Pharmaceutical Inc. | 1.46B | -3.01% | 2,783,933 | 717.00M |
| 331 | INNV | InnovAge Holding Corp. | 1.43B | -2.14% | 200,027 | 949.17M |
| 332 | ANRO | Alto Neuroscience, Inc. | 1.43B | 2.19% | 204,957 | - |
| 333 | SVRA | Savara Inc. | 1.42B | 3.82% | 803,443 | - |
| 334 | ATEC | Alphatec Holdings, Inc. | 1.42B | -2.96% | 906,176 | 815.05M |
| 335 | TNDM | Tandem Diabetes Care, Inc. | 1.41B | 1.96% | 640,212 | 1.04B |
| 336 | HROW | Harrow, Inc. | 1.41B | -2.48% | 222,902 | 275.59M |
| 337 | CNMD | CONMED Corporation | 1.40B | -5.33% | 129,557 | 1.37B |
| 338 | OMER | Omeros Corporation | 1.40B | 1.90% | 399,625 | 38.42M |
| 339 | REPL | Replimune Group, Inc. | 1.40B | -1.46% | 432,669 | - |
| 340 | AKTS | Aktis Oncology, Inc. | 1.39B | -7.91% | 237,427 | 10.06M |
| 341 | DRTS | Alpha Tau Medical Ltd. | 1.38B | -0.40% | 373,866 | - |
| 342 | OMDA | Omada Health, Inc. | 1.38B | -1.14% | 433,156 | 309.76M |
| 343 | CGEM | Cullinan Therapeutics, Inc. | 1.38B | -3.21% | 448,757 | - |
| 344 | AZTA | Azenta, Inc. | 1.37B | -0.05% | 290,552 | 613.81M |
| 345 | PNTG | The Pennant Group, Inc. | 1.36B | 2.34% | 71,561 | 1.10B |
| 346 | ALMS | Alumis Inc. | 1.35B | -6.22% | 1,741,028 | 7.40M |
| 347 | MNKD | MannKind Corporation | 1.34B | 2.96% | 3,253,833 | 393.63M |
| 348 | ORIC | ORIC Pharmaceuticals, Inc. | 1.33B | -0.54% | 290,681 | - |
| 349 | ODTX | Odyssey Therapeutics, Inc. | 1.32B | -4.55% | 72,762 | 99.00K |
| 350 | MGTX | MeiraGTx Holdings plc | 1.31B | -1.66% | 258,818 | 397.50M |
| 351 | NUTX | Nutex Health Inc. | 1.30B | -1.42% | 121,895 | 846.72M |
| 352 | SPTX | Seaport Therapeutics, Inc. | 1.30B | -2.13% | 79,909 | - |
| 353 | AMN | AMN Healthcare Services, Inc. | 1.30B | -0.59% | 164,046 | 3.43B |
| 354 | MLTX | MoonLake Immunotherapeutics | 1.29B | 0.87% | 694,583 | - |
| 355 | IMTX | Immatics N.V. | 1.29B | -1.46% | 375,865 | 47.65M |
| 356 | JBIO | Jade Biosciences, Inc. | 1.27B | 0.15% | 355,848 | - |
| 357 | IART | Integra LifeSciences Holdings Corporation | 1.27B | -2.63% | 243,479 | 1.65B |
| 358 | AORT | Artivion, Inc. | 1.24B | -0.57% | 224,692 | 471.47M |
| 359 | JANX | Janux Therapeutics, Inc. | 1.23B | -0.40% | 274,766 | 24.00M |
| 360 | PRCT | PROCEPT BioRobotics Corporation | 1.22B | -6.63% | 596,839 | 337.34M |
| 361 | GDRX | GoodRx Holdings, Inc. | 1.21B | 1.58% | 400,182 | 785.23M |
| 362 | GLUE | Monte Rosa Therapeutics, Inc. | 1.21B | 2.13% | 475,705 | 28.73M |
| 363 | CRON | Cronos Group Inc. | 1.20B | -0.46% | 591,858 | 179.09M |
| 364 | STAA | STAAR Surgical Company | 1.20B | 1.75% | 642,324 | 339.59M |
| 365 | CRVS | Corvus Pharmaceuticals, Inc. | 1.19B | -1.60% | 458,921 | - |
| 366 | CERT | Certara, Inc. | 1.18B | -2.27% | 693,992 | 421.75M |
| 367 | OBX | Obsidian Therapeutics, Inc. | 1.18B | 13.67% | 347,289 | - |
| 368 | USPH | U.S. Physical Therapy, Inc. | 1.17B | -0.91% | 74,185 | 804.27M |
| 369 | BVS | Bioventus Inc. | 1.17B | -1.35% | 180,217 | 581.85M |
| 370 | OPK | OPKO Health, Inc. | 1.16B | -5.49% | 1,392,577 | 587.90M |
| 371 | TDOC | Teladoc Health, Inc. | 1.15B | 0.96% | 2,139,075 | 2.49B |
| 372 | ATTO | Attovia Therapeutics, Inc. | 1.15B | -1.45% | 155,200 | 1.80M |
| 373 | KURA | Kura Oncology, Inc. | 1.15B | -2.72% | 705,307 | 77.23M |
| 374 | SANA | Sana Biotechnology, Inc. | 1.12B | -2.99% | 1,343,145 | - |
| 375 | IVA | Inventiva S.A. | 1.11B | -2.09% | 831,222 | 7.94M |
| 376 | ENOV | Enovis Corporation | 1.11B | 3.34% | 1,507,755 | 2.30B |
| 377 | LMRI | Lumexa Imaging Holdings, Inc. | 1.10B | -6.16% | 134,623 | 1.04B |
| 378 | GMRS | GMR Solutions Inc. | 1.08B | 3.64% | 262,425 | 5.88B |
| 379 | IRMD | IRADIMED CORPORATION | 1.08B | 1.51% | 43,846 | 86.34M |
| 380 | AVTX | Avalo Therapeutics, Inc. | 1.07B | 3.80% | 499,771 | 59.00K |
| 381 | SLDB | Solid Biosciences Inc. | 1.06B | -3.56% | 290,816 | - |
| 382 | FTH | Faeth Therapeutics, Inc. | 1.05B | 1.31% | 191,514 | - |
| 383 | PCRX | Pacira BioSciences, Inc. | 1.03B | -1.56% | 122,859 | 746.16M |
| 384 | ABUS | Arbutus Biopharma Corporation | 1.03B | 0.68% | 1,537,336 | 181.72M |
| 385 | ANL | Adlai Nortye Group Ltd. | 1.02B | 5.40% | 152,408 | 18.06M |
| 386 | CSTL | Castle Biosciences, Inc. | 1.01B | - | 86,617 | 357.28M |
| 387 | LXRX | Lexicon Pharmaceuticals, Inc. | 996.70M | - | 783,011 | 41.47M |
| 388 | SGP | SpyGlass Pharma, Inc. | 986.88M | 1.95% | 61,741 | - |
| 389 | GERN | Geron Corporation | 973.35M | -3.50% | 4,017,774 | 204.56M |
| 390 | WVE | Wave Life Sciences, Inc. | 972.43M | 1.54% | 1,735,619 | 65.37M |
| 391 | AMPH | Amphastar Pharmaceuticals, Inc. | 971.57M | -1.47% | 124,428 | 730.02M |
| 392 | CADL | Candel Therapeutics, Inc. | 968.73M | -0.94% | 610,849 | - |
| 393 | OLMA | Olema Pharmaceuticals, Inc. | 965.97M | 2.70% | 362,779 | - |
| 394 | IMMX | Immix Biopharma, Inc. | 956.48M | -3.88% | 630,051 | - |
| 395 | DSGN | Design Therapeutics, Inc. | 950.62M | 0.33% | 426,956 | - |
| 396 | CBLL | CeriBell, Inc. | 937.58M | -1.17% | 121,233 | 101.96M |
| 397 | ARDX | Ardelyx, Inc. | 933.21M | -0.93% | 1,363,408 | 450.89M |
| 398 | QDEL | QuidelOrtho Corporation | 920.97M | -3.87% | 295,094 | 2.67B |
| 399 | HELP | Cybin Inc. | 913.25M | 2.29% | 1,046,135 | - |
| 400 | CLYM | Climb Bio, Inc. | 912.95M | 2.42% | 461,593 | - |
| 401 | CBIO | Crescent Biopharma, Inc. | 900.53M | 0.77% | 190,610 | 11.88M |
| 402 | ANNX | Annexon, Inc. | 896.71M | -2.87% | 953,336 | - |
| 403 | ACRS | Aclaris Therapeutics, Inc. | 892.03M | -1.78% | 1,349,534 | 8.22M |
| 404 | RIGL | Rigel Pharmaceuticals, Inc. | 888.79M | -2.24% | 108,763 | 276.79M |
| 405 | TBPH | Theravance Biopharma, Inc. | 886.77M | - | 89,114 | 104.31M |
| 406 | BBNX | Beta Bionics, Inc. | 873.25M | -0.05% | 337,830 | 119.01M |
| 407 | AVR | Anteris Technologies Global Corp. | 860.56M | -2.32% | 234,420 | 2.24M |
| 408 | INMD | InMode Ltd. | 857.04M | - | 278,765 | 374.63M |
| 409 | FDMT | 4D Molecular Therapeutics, Inc. | 840.82M | 1.67% | 285,008 | 92.01M |
| 410 | HSTM | HealthStream, Inc. | 840.36M | -1.58% | 127,531 | 321.12M |
| 411 | ACHV | Achieve Life Sciences, Inc. | 839.68M | -3.89% | 1,614,398 | - |
| 412 | SIBN | SI-BONE, Inc. | 832.73M | 0.43% | 152,323 | 213.60M |
| 413 | SLN | Silence Therapeutics plc | 829.68M | -5.55% | 684,068 | 615.00K |
| 414 | AHCO | AdaptHealth Corp. | 826.47M | -4.55% | 1,021,893 | 3.36B |
| 415 | PHAR | Pharming Group N.V. | 808.19M | 3.03% | 16,634 | 366.48M |
| 416 | DBVT | DBV Technologies S.A. | 801.91M | -1.19% | 136,258 | 5.04M |
| 417 | CTMX | CytomX Therapeutics, Inc. | 792.06M | -2.02% | 756,468 | 18.30M |
| 418 | GLAS | Glass House Brands Inc. | 785.04M | -6.19% | 505,519 | 176.98M |
| 419 | MNPR | Monopar Therapeutics Inc. | 783.78M | -0.67% | 60,618 | - |
| 420 | VREX | Varex Imaging Corporation | 780.16M | - | 212,484 | 865.00M |
| 421 | NVCT | Nuvectis Pharma, Inc. | 776.09M | -2.74% | 68,754 | - |
| 422 | MPLT | MapLight Therapeutics, Inc. | 768.89M | 0.47% | 215,727 | - |
| 423 | ZVRA | Zevra Therapeutics, Inc. | 762.49M | 3.55% | 549,156 | 136.07M |
| 424 | AURA | Aura Biosciences, Inc. | 761.19M | -2.91% | 212,778 | - |
| 425 | AGMB | AgomAb Therapeutics NV | 760.88M | -2.09% | 197,389 | - |
| 426 | COLL | Collegium Pharmaceutical, Inc. | 760.50M | -0.72% | 496,982 | 808.21M |
| 427 | VSTM | Verastem, Inc. | 758.02M | 2.07% | 2,290,119 | 87.53M |
| 428 | PHAT | Phathom Pharmaceuticals, Inc. | 756.17M | 0.21% | 578,102 | 239.66M |
| 429 | GYRE | Gyre Therapeutics, Inc. | 754.96M | 3.79% | 159,821 | 109.82M |
| 430 | OCS | Oculis Holding AG | 753.75M | 0.33% | 53,257 | 1.45M |
| 431 | NGNE | Neurogene Inc. | 753.33M | -2.47% | 75,791 | 925.00K |
| 432 | AHG | Akso Health Group | 737.18M | 1.47% | 17,933 | 13.83M |
| 433 | ASMB | Assembly Biosciences, Inc. | 720.97M | -3.25% | 104,903 | 74.85M |
| 434 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 711.15M | -1.22% | 46,948 | - |
| 435 | SOPH | SOPHiA GENETICS SA | 707.84M | 2.78% | 299,066 | 86.17M |
| 436 | BLSM | BlossomHill Therapeutics, Inc. | 689.79M | 2.27% | 132,521 | - |
| 437 | IRWD | Ironwood Pharmaceuticals, Inc. | 684.09M | -2.82% | 1,012,792 | 389.32M |
| 438 | SGMT | Sagimet Biosciences Inc. | 680.64M | 0.09% | 467,591 | - |
| 439 | SSII | SS Innovations International, Inc. | 671.29M | -1.76% | 10,927 | 52.40M |
| 440 | MDXG | MiMedx Group, Inc. | 671.23M | 0.77% | 462,029 | 355.17M |
| 441 | STTK | Shattuck Labs, Inc. | 667.92M | -1.99% | 402,785 | 1.00M |
| 442 | EVO | Evotec SE | 664.29M | -2.15% | 20,111 | 819.47M |
| 443 | DRUG | Bright Minds Biosciences Inc. | 656.57M | -0.25% | 25,364 | - |
| 444 | ALT | Altimmune, Inc. | 656.50M | -1.32% | 2,206,551 | 31.00K |
| 445 | AQST | Aquestive Therapeutics, Inc. | 652.66M | -2.62% | 1,186,128 | 54.09M |
| 446 | CTEV | Claritev Corporation | 648.41M | -0.44% | 35,576 | 994.67M |
| 447 | ALLO | Allogene Therapeutics, Inc. | 646.07M | -5.08% | 4,667,339 | 4.64M |
| 448 | CRMD | CorMedix Inc. | 643.04M | -2.14% | 625,108 | 462.25M |
| 449 | PHR | Phreesia, Inc. | 641.19M | -5.58% | 382,967 | 507.79M |
| 450 | STLN | Starling Oncology, Inc. | 641.05M | 6.07% | 568,209 | 587.24M |
| 451 | VALN | Valneva SE | 637.30M | 0.73% | 15,360 | 163.30M |
| 452 | PRME | Prime Medicine, Inc. | 631.56M | -4.05% | 1,608,324 | 4.07M |
| 453 | ANGO | AngioDynamics, Inc. | 629.29M | 0.16% | 119,584 | 320.17M |
| 454 | CTNM | Contineum Therapeutics, Inc. | 613.98M | -2.28% | 132,283 | - |
| 455 | OABI | OmniAb, Inc. | 607.73M | -3.46% | 474,368 | 38.46M |
| 456 | CTKB | Cytek Biosciences, Inc. | 607.02M | -0.64% | 260,392 | 206.71M |
| 457 | PROK | ProKidney Corp. | 606.16M | -0.25% | 498,593 | 818.00K |
| 458 | TLRY | Tilray Brands, Inc. | 605.50M | -1.78% | 2,496,096 | 915.45M |
| 459 | ARVN | Arvinas, Inc. | 600.90M | -2.13% | 159,140 | 316.70M |
| 460 | TECX | Tectonic Therapeutic, Inc. | 598.80M | -0.39% | 45,492 | - |
| 461 | ZURA | Zura Bio Limited | 592.22M | -0.80% | 773,098 | - |
| 462 | EOLS | Evolus, Inc. | 591.15M | -3.76% | 673,921 | 316.49M |
| 463 | EIKN | Eikon Therapeutics, Inc. | 590.67M | 0.41% | 235,003 | - |
| 464 | WEAV | Weave Communications, Inc. | 585.59M | -0.14% | 643,719 | 257.79M |
| 465 | SCTX | Scribe Therapeutics Inc. | 575.71M | 6.07% | 139,787 | 33.30M |
| 466 | RGNX | REGENXBIO Inc. | 575.64M | -2.46% | 361,441 | 174.48M |
| 467 | KIDS | OrthoPediatrics Corp. | 574.28M | -1.85% | 59,123 | 252.72M |
| 468 | CABA | Cabaletta Bio, Inc. | 569.67M | -3.17% | 1,521,882 | - |
| 469 | AUTL | Autolus Therapeutics plc | 565.60M | -5.13% | 1,720,288 | 117.39M |
| 470 | DCTH | Delcath Systems, Inc. | 559.69M | -2.12% | 102,793 | 95.42M |
| 471 | BWAY | BrainsWay Ltd. | 557.83M | 1.45% | 33,089 | 60.70M |
| 472 | EPRX | Eupraxia Pharmaceuticals Inc. | 554.49M | 1.31% | 210,385 | - |
| 473 | PRLD | Prelude Therapeutics Incorporated | 553.60M | -1.56% | 110,338 | 22.42M |
| 474 | FLGT | Fulgent Genetics, Inc. | 550.58M | 1.42% | 159,096 | 323.93M |
| 475 | SPRY | ARS Pharmaceuticals, Inc. | 541.99M | -3.02% | 513,683 | 116.93M |
| 476 | OVID | Ovid Therapeutics Inc. | 541.95M | -0.89% | 403,343 | 1.58M |
| 477 | ARTV | Artiva Biotherapeutics, Inc. | 534.37M | -2.32% | 106,078 | 251.00K |
| 478 | CAPR | Capricor Therapeutics, Inc. | 532.55M | -2.55% | 1,465,916 | 11.13M |
| 479 | CERS | Cerus Corporation | 517.92M | -0.77% | 360,367 | 221.55M |
| 480 | NPCE | NeuroPace, Inc. | 511.77M | 0.07% | 54,454 | 106.99M |
| 481 | ENTX | Entera Bio Ltd. | 507.31M | -2.33% | 340,612 | 42.00K |
| 482 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 483 | KYTX | Kyverna Therapeutics, Inc. | 504.02M | -1.21% | 307,006 | - |
| 484 | SENS | Senseonics Holdings, Inc. | 503.89M | -1.04% | 262,030 | 48.55M |
| 485 | PRTA | Prothena Corporation plc | 495.40M | -1.73% | 93,315 | 54.53M |
| 486 | PBYI | Puma Biotechnology, Inc. | 492.46M | -0.10% | 209,551 | 231.24M |
| 487 | TCMD | Tactile Systems Technology, Inc. | 491.78M | -0.73% | 105,418 | 350.31M |
| 488 | EVH | Evolent Health, Inc. | 485.02M | -0.69% | 1,180,983 | 2.10B |
| 489 | KMDA | Kamada Ltd. | 477.05M | -3.40% | 293,559 | 191.85M |
| 490 | RZLT | Rezolute, Inc. | 470.62M | -1.64% | 308,588 | - |
| 491 | DNA | Ginkgo Bioworks Holdings, Inc. | 470.37M | 0.50% | 381,141 | 132.42M |
| 492 | NRC | NRC Health | 469.27M | -1.46% | 53,879 | 140.00M |
| 493 | EDIT | Editas Medicine, Inc. | 466.88M | -5.88% | 1,287,628 | 47.01M |
| 494 | SRTA | Strata Critical Medical, Inc. | 466.22M | -0.94% | 414,072 | 255.98M |
| 495 | AVIR | Atea Pharmaceuticals, Inc. | 462.78M | -1.03% | 65,052 | - |
| 496 | EVMN | Evommune, Inc. | 459.10M | 3.10% | 762,271 | 10.00M |
| 497 | OCGN | Ocugen, Inc. | 452.71M | -1.84% | 1,617,345 | 4.58M |
| 498 | CCCC | C4 Therapeutics, Inc. | 451.50M | -2.39% | 1,435,497 | 35.04M |
| 499 | ARCT | Arcturus Therapeutics Holdings Inc. | 449.08M | -0.13% | 309,249 | 29.37M |
| 500 | RLMD | Relmada Therapeutics, Inc. | 449.08M | -4.97% | 754,308 | - |